AMANDA MILLER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GULFPORT, MS NPI 1609274604

General Payments — all program years on this page

$1,670.23

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 76
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $452.15 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $452.1518

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $138.505
ABBVIE INC. $131.472
Novo Nordisk AS $48.413
Lilly USA, LLC $45.083
Amgen Inc. $32.852
GlaxoSmithKline, LLC. $29.452
Boehringer Ingelheim Pharmaceuticals, Inc. $26.391

By program year

Program yearAmountRecords
2021 $121.129
2022 $466.6017
2023 $630.3632
2024 $452.1518

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100235086 Novo Nordisk Inc $16.58 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100366101 Novo Nordisk Inc $17.14 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100369477 Novo Nordisk Inc $14.69 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104549800 AstraZeneca Pharmaceuticals LP $13.35 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104724489 AstraZeneca Pharmaceuticals LP $51.40 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105307783 AstraZeneca Pharmaceuticals LP $13.95 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105451337 AstraZeneca Pharmaceuticals LP $41.03 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105679079 AstraZeneca Pharmaceuticals LP $18.77 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107661998 ABBVIE INC. $104.94 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107662000 ABBVIE INC. $26.53 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115932720 Amgen Inc. $14.43 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116235682 GlaxoSmithKline, LLC. $16.34 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116708279 GlaxoSmithKline, LLC. $13.11 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117630102 Amgen Inc. $18.42 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118077412 Boehringer Ingelheim Pharmaceuticals, Inc. $26.39 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135518478 Lilly USA, LLC $14.86 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135518480 Lilly USA, LLC $15.11 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135528147 Lilly USA, LLC $15.11 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.